Zhou, Jinpeng http://orcid.org/0000-0002-8915-9039
Jiang, Yang
Zhang, Haiying
Chen, Lian
Luo, Peng
Li, Long
Zhao, Junshuang
Lv, Fei
Zou, Dan
Zhang, Ye
Jing, Zhitao
Funding for this research was provided by:
National Natural Science Foundation of China (81270036, 30901736, 81101917)
the Plan to Focus on Research and Development from Science and Technology project of Liaoning Province (2017225029)
Liaoning Province Natural Science Foundation (20170541022)
Science and Technology Plan Project of Shenyang City (18-014-4-11)
Fund for Scientific Research of The First Hospital Of China Medical University (FHCMU- FSR)
Article History
Received: 16 August 2018
Accepted: 24 May 2019
First Online: 13 June 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interests.
: The study was approved by the Research Ethics Committee of the First Hospital of China Medical University and was in accordance with the ethical standards of the institutional committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study approval number is AF-SOP-07-01.
: Informed consent was obtained from all individual participants included in the study. With approval from the National Science Foundation of China (81101917), we designed informed consent forms that were signed by eligible patients before recruitment into the study and admission to the hospital. The patients agreed to the use of their specimens and clinical data for research purposes only.
: The human chordoma cell line UM-Chor1 was obtained as a gift from Professor Yazhuo Zhang, Department of Neurosurgery, Beijing Tiantan Hospital. The origin of UM-Chor1 was human clivus chordoma tissue. The American Type Culture Collection (ATCC) performed authentication of cell line UM-Chor1 via cytochrome C oxidase I assay and short tandem repeat analysis. We obtained a cell line authentication certificate from the ATCC.